Stockreport

aTyr Pharma Spotlights Efzofitimod Phase 3 Learnings, Eyes Mid-April FDA Type C Meeting [Yahoo! Finance]

aTyr Pharma, Inc.  (ATYR) 
PDF placebo steroid withdrawal was higher than expected, but the 5 mg/kg dose showed statistically significant quality-of-life improvements (KSQ lung), a positive steroid-fr [Read more]